Human monkeypox infection re-emerges amid the COVID-19 crisis: A review

Background: Monkeypox is a re-emerging viral disease that has recently negatively affected the lives of many people in different countries of the world and has caused many concerns. One of the concerns about this virus is that it will become a new pandemic in the context of the ongoing COVID-19 pandemic. While the world is still struggling with the COVID-19 pandemic, the newly emerging viral disease monkeypox first broke out in the United Kingdom on April 29, 2022, amid the coronavirus crisis. Methodology: This review was carried out by searching articles using the keywords monkeypox, epidemic, covid-19, and emerging infection in various databases and extraction of relevant data based on inclusion and exclusion criteria. Discussion: Considering that the monkeypox virus is the cause of acute infections in humans and animals, it can have many effects on the overall population structure and economic issues of a country and threaten the health of human and animal populations. It can spread via direct and indirect contact both between humans and humans and animals. Asymptomatic patients are also able to spread the disease. Now that routine human smallpox vaccination has discontinued and herd immunity is declining, new assessments of monkeypox are required. Furthermore, basic ecological studies are required to better understand the animal species involved in virus transmission and maintenance, as well as to influence future preventive actions. Therefore, knowing different aspects of this disease, its prevention, and treatment methods are quite important.   Conclusion: Although cases of this disease have been reported in many non-endemic countries of the world, and we should be prepared for its prevention and proper treatment but considering its slower transmission method it seems that this disease can be controlled and prevented much more easily than COVID-19